Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism (Q40494164)

21 September 2017

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism (English)

1 reference

Duchenne muscular dystrophy

21 September 2017

0 references

1 reference

Geoffrey Camirand

1

1 reference

21 September 2017

Joël Rousseau

2

1 reference

21 September 2017

Marie-Eve Ducharme

3

1 reference

21 September 2017

David M Rothstein

4

1 reference

21 September 2017

Jacques P Tremblay

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

American Journal of Transplantation

21 September 2017

1 reference

21 September 2017

4

1 reference

21 September 2017

8

1 reference

21 September 2017

1255-1265

1 reference

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Progress in myoblast transplantation: a potential treatment of dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Normal myoblast implantation in MDX mice prevents muscle damage by exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Mixed chimerism and transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Muscle regeneration by bone marrow-derived myogenic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Dystrophin expression in the mdx mouse restored by stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00501.X

10.1111/J.1600-6143.2004.00501.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference